Foreign Courts and Rulings

Total 142 Posts

U.S. Court Finds Errors in Forced Labor Decision, Remands for Reconsideration

In a ruling issued on Friday, a U.S. Court of International Trade judge ordered that a decision not to remove a Chinese company from the Uyghur Forced Labor Prevention Act (UFLPA) Entity List be remanded for further consideration.

Appeal in DJI "Chinese Military Company" Case Reverses Lower Court Ruling, Remands for Further Proceedings

Chinese drone maker Shenzhen DJI Innovation Technology Co., known as DJI, succeeded on one of its claims in an appeal in U.S. court, and will now have another chance to convince a lower court that its designation by the U.S. Department of Defense as a "Chinese Military

U.S. Government Responds to Alibaba Free Speech Injunction Motion in "Chinese Military Company" Case

In a recent court filing, the Trump administration responded to a motion for an injunction filed by Chinese tech giant Alibaba on free speech grounds in a case involving the designation of Alibaba as a "Chinese Military Company" (CMC).

U.S. Court Issues Injunction Blocking Designation of WuXi as Chinese Military Company

In a decision issued on Friday, a U.S. federal court issued a preliminary injunction blocking the U.S. Department of Defense's designation of Chinese biotech company Wuxi AppTec as a "Chinese military company."

EU Court Rejects Request for Interim Measures in Foreign Subsidies Regulation Case

In an order issued earlier this week, the EU General Court has rejected a request from a Chinese wind turbine maker for suspension of a European Commission decision to request more information as part of a Foreign Subsidies Regulation investigation.

U.S. Government Responds To WuXi Motion for Preliminary Injunction in Chinese Military Company Designation Case

The Trump administration has filed its response to a request for a preliminary injunction in a case involving the Department of Defense's decision to designate a Chinese biotech company as a "Chinese Military Company."

Alibaba to Pay $600 Million over U.S. Illicit Drug Sales Charges

Last week, Chinese e-commerce giant Alibaba and its U.S. payment processor agreed to pay $600 million to settle U.S. government allegations that they let merchants use their platforms to smuggle illegal pharmaceuticals and pill presses into the United States.
You've successfully subscribed to China Trade Monitor
Great! Next, complete checkout for full access to China Trade Monitor
Welcome back! You've successfully signed in.
Unable to sign you in. Please try again.
Success! Your account is fully activated, you now have access to all content.
Error! Stripe checkout failed.
Success! Your billing info is updated.
Error! Billing info update failed.